Literature DB >> 16133361

Growth pattern and distribution of follicular dendritic cells in mantle cell lymphoma: a clinicopathological study of 96 patients.

Carsten Schrader1, Peter Meusers, Günter Brittinger, Dirk Janssen, Afshin Teymoortash, Jens U Siebmann, Reza Parwaresch, Markus Tiemann.   

Abstract

Mantle cell lymphoma (MCL) is an aggressive lymphoma with accepted risk factors such as proliferation markers. To date, the different follicular dendritic cell (FDC) patterns have never been analyzed in comparison with the overall survival time. Lymph node biopsy specimens from 96 patients were analyzed by conventional morphology and immunohistochemistry with antibodies against cluster differentiation (CD)20, CD5, CD23, cyclin D1, and FDC (Ki-M4P). Two groups can be distinguished with different FDC patterns: a nodular pattern in 79 cases and a diffuse pattern in 17 cases. A Kaplan-Meier analysis revealed significantly better survival for the nodular group (p=0.0312). This group was subdivided into a group with a nodular FDC pattern similar to the FDC distribution in primary follicles (PF-nodular in 72 cases) and one with a nodular FDC pattern resembling the colonization of germinal centers (GCs) by tumor cells (GC-nodular in seven cases). A Kaplan-Meier analysis showed that patients with MCL with a PF-nodular FDC pattern had a significantly better clinical outcome than patients with the other two patterns (p=0.0033). If only cases with classical cytology (n=79) were analyzed (blastoid types excluded), patients with a PF-nodular FDC pattern had a better clinical outcome (p=0.0008). The distribution of FDC in MCL is a diagnostic tool for identifying patients with a better clinical prognosis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16133361     DOI: 10.1007/s00428-005-0049-5

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  54 in total

1.  Blastic transformation of mantle cell lymphoma: genetic evidence for a clonal link between the two stages of the tumour.

Authors:  T László; A Matolcsy
Journal:  Histopathology       Date:  1999-10       Impact factor: 5.087

2.  Follicular dendritic cells and T cells: nurses and executioners in the germinal centre reaction.

Authors:  C Hollmann; J Gerdes
Journal:  J Pathol       Date:  1999-10       Impact factor: 7.996

3.  Mantle cell lymphoma. A proposal for unification of morphologic, immunologic, and molecular data.

Authors:  P M Banks; J Chan; M L Cleary; G Delsol; C De Wolf-Peeters; K Gatter; T M Grogan; N L Harris; P G Isaacson; E S Jaffe
Journal:  Am J Surg Pathol       Date:  1992-07       Impact factor: 6.394

4.  Characterization of two CD23 monoclonal antibodies with reactivity distinct from other antibodies within this cluster of differentiation.

Authors:  L K Goff; R J Armitage; P C Beverley
Journal:  Immunology       Date:  1988-10       Impact factor: 7.397

5.  Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.

Authors:  S M Hsu; L Raine; H Fanger
Journal:  J Histochem Cytochem       Date:  1981-04       Impact factor: 2.479

6.  Mantle-zone lymphoma: a follicular variant of intermediate lymphocytic lymphoma.

Authors:  D D Weisenburger; H Kim; H Rappaport
Journal:  Cancer       Date:  1982-04-01       Impact factor: 6.860

7.  The value of immunohistochemistry on paraffin wax embedded tissue sections in the differentiation of small lymphocytic and mantle cell lymphomas.

Authors:  N Singh; D H Wright
Journal:  J Clin Pathol       Date:  1997-01       Impact factor: 3.411

8.  A clinical analysis of two indolent lymphoma entities: mantle cell lymphoma and marginal zone lymphoma (including the mucosa-associated lymphoid tissue and monocytoid B-cell subcategories): a Southwest Oncology Group study.

Authors:  R I Fisher; S Dahlberg; B N Nathwani; P M Banks; T P Miller; T M Grogan
Journal:  Blood       Date:  1995-02-15       Impact factor: 22.113

9.  The morphologic spectrum of non-Hodgkin's lymphomas with BCL1/cyclin D1 gene rearrangements.

Authors:  S H Swerdlow; L R Zukerberg; W I Yang; N L Harris; M E Williams
Journal:  Am J Surg Pathol       Date:  1996-05       Impact factor: 6.394

10.  Malignant lymphoma, intermediate lymphocytic type: a clinicopathologic study of 42 cases.

Authors:  D D Weisenburger; B N Nathwani; L W Diamond; C D Winberg; H Rappaport
Journal:  Cancer       Date:  1981-09-15       Impact factor: 6.860

View more
  3 in total

1.  Follicular dendritic cell-dependent drug resistance of non-Hodgkin lymphoma involves cell adhesion-mediated Bim down-regulation through induction of microRNA-181a.

Authors:  Tint Lwin; Jianhong Lin; Yong Sung Choi; Xinwei Zhang; Lynn C Moscinski; Kenneth L Wright; Eduardo M Sotomayor; William S Dalton; Jianguo Tao
Journal:  Blood       Date:  2010-09-14       Impact factor: 22.113

2.  A microenvironment-mediated c-Myc/miR-548m/HDAC6 amplification loop in non-Hodgkin B cell lymphomas.

Authors:  Tint Lwin; Xiaohong Zhao; Fengdong Cheng; Xinwei Zhang; Andy Huang; Bijal Shah; Yizhuo Zhang; Lynn C Moscinski; Yong Sung Choi; Alan P Kozikowski; James E Bradner; William S Dalton; Eduardo Sotomayor; Jianguo Tao
Journal:  J Clin Invest       Date:  2013-11       Impact factor: 14.808

3.  Genomic profiles and clinical outcomes of de novo blastoid/pleomorphic MCL are distinct from those of transformed MCL.

Authors:  Preetesh Jain; Shaojun Zhang; Rashmi Kanagal-Shamanna; Chi Young Ok; Krystle Nomie; Graciela Nogueras Gonzalez; Omarya Gonzalez-Pagan; Holly A Hill; Hun Ju Lee; Luis Fayad; Jason Westin; Loretta Nastoupil; Frederick Hagemeister; Wendy Chen; Onyeka Oriabure; Maria Badillo; Changying Jiang; Yao Yixin; Shaoying Li; Guilin Tang; C Cameron Yin; Keyur P Patel; Leonard Jeffrey Medeiros; Ranjit Nair; Sairah Ahmed; Swaminathan P Iyer; Selvi Thirumurthi; Richard Champlin; Guofan Xu; Pan Tinsu; David Santos; Ruiping Wang; Guangchun Han; Jianhua Zhang; Xingzhi Song; Sattva Neelapu; Jorge Romaguera; Andy Futreal; Christopher Flowers; Nathan Fowler; Linghua Wang; Michael L Wang
Journal:  Blood Adv       Date:  2020-03-24
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.